What is the appropriate cefixime dosing for a pregnant woman with an uncomplicated urinary tract infection, including adjustment for creatinine clearance <30 mL/min?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cefixime Dosing for Pregnant Women with Uncomplicated UTI

For a pregnant woman with uncomplicated UTI and normal renal function, administer cefixime 400 mg once daily orally; with creatinine clearance <30 mL/min, reduce to 200 mg once daily (or 8.6 mL of 100 mg/5 mL suspension). 1

Standard Dosing

The FDA-approved dosing for uncomplicated urinary tract infections is straightforward:

  • Adults with normal renal function: 400 mg once daily 1
  • Administration: Can be taken without regard to food 1
  • Duration: While the FDA label doesn't specify duration for UTI, clinical guidelines suggest β-lactams require longer courses than fluoroquinolones or TMP-SMX 2

Renal Dose Adjustment

Critical dosing adjustments based on creatinine clearance 1:

Creatinine Clearance Dose Adjustment
≥60 mL/min 400 mg daily (normal dose)
21-59 mL/min 260 mg daily (13 mL of 100 mg/5 mL suspension OR 6.5 mL of 200 mg/5 mL suspension)
<20 mL/min 200 mg daily (8.6 mL of 100 mg/5 mL suspension OR 4.4 mL of 200 mg/5 mL suspension)

For your specific patient with CrCl <30 mL/min, this falls into the <20 mL/min category requiring 50% dose reduction to 200 mg once daily 1.

Pregnancy Considerations

Cefixime is considered safe during pregnancy with important caveats:

  • FDA classification: Should be used "only if clearly needed" during pregnancy 1
  • Pharmacokinetics remain stable during pregnancy with minimal fetal tissue penetration (<1% of dose) 3
  • High oral bioavailability and resistance to β-lactamases make it effective for UTI treatment 3
  • Recent evidence confirms cefixime as a rational choice for uncomplicated UTI in pregnant women due to high E. coli sensitivity, safety profile, and compliance 4

Clinical Context and Limitations

Important caveats about β-lactam use for UTI:

While cefixime is FDA-approved for uncomplicated UTI 1, current guidelines reveal significant limitations:

  • β-lactams have inferior efficacy compared to fluoroquinolones, TMP-SMX, and nitrofurantoin for cystitis 5
  • Guidelines state β-lactams should be used "with caution" and "only when other recommended agents cannot be used" 5
  • Insufficient evidence exists for optimal treatment duration with β-lactams for cystitis 2
  • For pyelonephritis, β-lactams are "less effective than other available agents" and require 10-14 days of therapy 5

Practical Algorithm

Decision pathway:

  1. Confirm diagnosis: Uncomplicated UTI in pregnant woman
  2. Check renal function:
    • CrCl ≥60 mL/min → 400 mg daily
    • CrCl 21-59 mL/min → 260 mg daily
    • CrCl <20 mL/min → 200 mg daily
  3. Consider alternatives first: Nitrofurantoin (5 days) or fosfomycin (single dose) are preferred if not contraindicated 4
  4. If cefixime chosen: Use adjusted dose, monitor clinical response closely given inferior efficacy data
  5. Duration: Minimum 7 days (extrapolated from β-lactam data) 2

Neither hemodialysis nor peritoneal dialysis removes significant amounts of cefixime, so no supplemental dosing is needed post-dialysis 1, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.